![](https://investorshub.advfn.com/uicon/29747.png?cb=1464811254)
Monday, May 13, 2024 7:58:46 AM
Recent RPHM News
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/19/2024 10:06:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 09:03:24 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/13/2024 08:03:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:00:10 PM
- Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 11:35:00 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/27/2024 01:59:05 AM
- Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm • PR Newswire (US) • 07/01/2024 07:13:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/13/2024 01:38:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:14:11 PM
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger • GlobeNewswire Inc. • 05/13/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:03:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:00:15 PM
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 11:35:00 AM
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update • GlobeNewswire Inc. • 03/28/2024 11:35:00 AM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:00:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:00 PM
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 12/14/2023 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:05 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 10:08:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2023 09:58:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:00:11 PM
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 12:35:00 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM